PAUL SIMMONS, APRN
Nursing at California St, Houston, TX

License number
Texas AP125157
Category
Nursing
Type
Gerontology
License number
Texas 607860
Category
Nursing
Type
Primary Care
Address
Address
1415 California St, Houston, TX 77006
Phone
(832) 548-5000

Personal information

See more information about PAUL SIMMONS at radaris.com
Name
Address
Phone
Paul Simmons
4900 Usaa Blvd, San Antonio, TX 78240
(210) 663-6438
Paul Simmons
5025 Ashlock Dr, The Colony, TX 75056
Paul Simmons, age 61
4420 N Hall St, Dallas, TX 75219
(214) 340-2528
Paul Simmons, age 67
4508 Mathis St, Midland, TX 79707
Paul Simmons, age 68
503 Uhland Rd TRLR 4, San Marcos, TX 78666

Organization information

See more information about PAUL SIMMONS at bizstanding.com

PAUL SIMMONS & ASSOCIATES INC

Houston, TX  -  Bellaire, TX

Status:
Inactive
Doing business as:
Baby Burgers, Incorporated<br>Paul Simmons & Associates, Inc
Registration:
Sep 4, 1984
Addresses:
11019 Doud St %Paul C Simmons, Houston, TX 77035 (Mailing)
704 Mulberry Ln, Bellaire, TX 77401
State ID:
0071941500
Business type:
Domestic For-Profit Corporation
DIRECTOR, President, Director:
Paul C Simmons DIRECTOR, President, Director, inactive, 708 Mulberry, Bellaire, TX 77401
TIN:
30008575562

Professional information

See more information about PAUL SIMMONS at trustoria.com
Paul Simmons Photo 1
Energy Consultant

Energy Consultant

Position:
Investor Relations at Taitale Studios, LNG & NG at Repsol Energy North America
Location:
Houston, Texas Area
Industry:
Oil & Energy
Work:
Taitale Studios - Global since Jan 2011 - Investor Relations Repsol Energy North America - Houston, Texas Area since Mar 2010 - LNG & NG CRW Energy - New York, New York Oct 2010 - Jun 2011 - VP - Energy Brokerage Derivatives (Crude & Products) K5NOLA Charity Sep 2009 - May 2010 - Partner/Coordinator Barclays Capital - London & New York Mar 2007 - Jul 2009 - Commodities, Assistant Vice President JPMorgan. London Wall - London, United Kingdom Jun 2005 - Mar 2007 - IRD PB J.P. Morgan - Bournemouth, United Kingdom Sep 2000 - Jun 2005 - Senior FXO/Bullion P&L/Risk Analyst
Education:
Bournemouth University
College Education
A' levels; C.S.E's, Business Studies; 9 No; includes Maths, English and Physics ­ Shaftesbury
Salisbury Technical College
A' levels, Business Studies
Interests:
Football (Soccer), Snowboarding, Triathlon, Golf, Kiteboarding
Languages:
French, Spanish


Paul Simmons Photo 2
Director Stem Cell Center At Brown Foundation Institute Of Molecular Medicine, Uthsc At Houston, Tx

Director Stem Cell Center At Brown Foundation Institute Of Molecular Medicine, Uthsc At Houston, Tx

Position:
Director Stem Cell Center at Brown Foundation Institute of Molecular Medicine, UTHSC at Houston, TX
Location:
Houston, Texas Area
Industry:
Biotechnology
Work:
Brown Foundation Institute of Molecular Medicine, UTHSC at Houston, TX - Director Stem Cell Center


Paul Simmons Photo 3
Vice President Business Develpoment At Hvj Associates, Inc

Vice President Business Develpoment At Hvj Associates, Inc

Position:
Vice President Business Develpoment at HVJ Associates, Inc
Location:
Houston, Texas Area
Industry:
Civil Engineering
Work:
HVJ Associates, Inc - Vice President Business Develpoment


Paul Simmons Photo 4
Independent Civil Engineering Professional

Independent Civil Engineering Professional

Location:
Houston, Texas Area
Industry:
Civil Engineering


Paul Simmons Photo 5
Isolation Of Adult Multipotential Cells By Tissue Non-Specific Alkaline Phosphatase

Isolation Of Adult Multipotential Cells By Tissue Non-Specific Alkaline Phosphatase

US Patent:
8367405, Feb 5, 2013
Filed:
Apr 12, 2006
Appl. No.:
11/918593
Inventors:
Stan Gronthos - Adelaide, AU
Andrew Christopher William Zannettino - Highbury, AU
Paul John Simmons - Houston TX, US
Assignee:
Mesoblast, Inc. - New York NY
International Classification:
C12N 5/074, C12N 5/077, C07K 16/40, C12P 21/08
US Classification:
435325, 435372, 435377, 5303881, 53038826
Abstract:
The present invention relates to the use of tissue non-specific alkaline phosphatase (TNAP) as a marker for identifying and/or isolating adult multipotential cells. The present invention also relates to cell populations enriched by methods of the present invention and therapeutic uses of these cells.